{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:19:04Z","timestamp":1791811144523,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd008765.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000}}],"reference-count":66,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008765.pub3","type":"journal-article","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T06:54:23Z","timestamp":1361602463000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Surgical cytoreduction for recurrent epithelial ovarian cancer"],"prefix":"10.1002","volume":"2016","author":[{"given":"Thuria","family":"Al Rawahi","sequence":"first","affiliation":[{"name":"The Royal Hospital; Department of Obstetrics and Gynaecology; PO Box 750, PC111 Seeb Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto D","family":"Lopes","sequence":"additional","affiliation":[{"name":"Princess Alexandra Wing, Royal Cornwall Hospital; Gynaecological Oncology; Truro Cornwall UK TR1 3LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E","family":"Bristow","sequence":"additional","affiliation":[{"name":"University of California - Irvine, Medical Center; Division of Gynecologic Oncology; Building 56, Room 260 101 The City Drive Orange CA USA 92868"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bryant","sequence":"additional","affiliation":[{"name":"Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elattar","sequence":"additional","affiliation":[{"name":"City Hospital & Birmingham Treatment Centre; Dudley Road Birmingham West Midlands UK B18 7QH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supratik","family":"Chattopadhyay","sequence":"additional","affiliation":[{"name":"St James's University Hospital; Gynaecological Oncology; Level 4, Bexley Wing Beckett Street Leeds UK LS9 7TF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadra","family":"Galaal","sequence":"additional","affiliation":[{"name":"Princess Alexandra Wing, Royal Cornwall Hospital; Gynaecological Oncology; Truro Cornwall UK TR1 3LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"key":"10.1002\/14651858.CD008765.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajog.2005.06.048","article-title":"The role of secondary cytoreduction in the treatment of ovarian: Hacettepe University experience","volume":"194","author":"Ayhan","year":"2006","journal-title":"American Journal of Obstetrics and Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD008765.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD008765.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma","volume":"88","author":"Eisenkop","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"10.1002\/14651858.CD008765.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Annals of Surgical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008765.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/annonc\/mdn591","article-title":"The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer","volume":"20","author":"Oksefjell","year":"2009","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"issue":"4","key":"10.1002\/14651858.CD008765.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/gyno.2001.6404","article-title":"Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma","volume":"83","author":"Scarabelli","year":"2001","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jso.21491","article-title":"Surgery in recurrent epithelial ovarian cancer: benefits on survival for patients with residual disease of 0.1 - 1 cm after secondary cytoreduction","volume":"101","author":"Tian","year":"2010","journal-title":"Journal of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD008765.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/1096-9098(200009)75:1<24::AID-JSO5>3.0.CO;2-L","article-title":"Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer","volume":"75","author":"Zang","year":"2000","journal-title":"Journal of Surgical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD008765.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","article-title":"Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer","volume":"14","author":"Benedetti Panici","year":"2006","journal-title":"Annals of Surgical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008765.pub3-BIB0011|cit11","first-page":"189","article-title":"Survival of patients following secondary cytoreductive surgery in ovarian cancer","volume":"61","author":"Berek","year":"1983","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD008765.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0090-8258(03)00336-6","article-title":"Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET\/CT","volume":"90","author":"Bristow","year":"2003","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008765.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2009.05.004","article-title":"Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome","volume":"114","author":"Bristow","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"9","key":"10.1002\/14651858.CD008765.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/1097-0142(19951101)76:9<1606::AID-CNCR2820760917>3.0.CO;2-H","article-title":"Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study","volume":"76","author":"Eisenkop","year":"1995","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD008765.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","article-title":"Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer","volume":"79","author":"Gadducci","year":"2000","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IGC.0b013e3182098002","article-title":"Potential survival benefit of secondary cytoreductive surgery for recurrent epithelial ovarian, tubal, and peritoneal cancers","volume":"21","author":"Goto","year":"2011","journal-title":"International Journal of Gynecological Cancer"},{"issue":"1","key":"10.1002\/14651858.CD008765.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejso.2004.08.016","article-title":"Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum","volume":"31","author":"Gronlund","year":"2005","journal-title":"European Journal of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD008765.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygyno.2004.11.057","article-title":"The role of secondary cytoreductive surgery for recurrent ovarian cancer","volume":"97","author":"Gungor","year":"2005","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD008765.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2006.10.051","article-title":"Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma","volume":"105","author":"Helm","year":"2007","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008765.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2006.08.037","article-title":"Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome","volume":"104","author":"Karam","year":"2007","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008765.pub3-BIB0021|cit21","first-page":"233","article-title":"Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy","volume":"77","author":"Landoni","year":"1998","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD008765.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1447-0756.2006.00460.x","article-title":"Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy","volume":"32","author":"Matsumoto","year":"2006","journal-title":"The Journal of Obstetrics and Gynaecology Research"},{"issue":"3","key":"10.1002\/14651858.CD008765.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0090-8258(89)90168-6","article-title":"Secondary cytoreductive surgery for recurrent epithelial ovarian cancer","volume":"34","author":"Morris","year":"1989","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008765.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.2001.6143","article-title":"Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer","volume":"81","author":"Munkarah","year":"2001","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD008765.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ygyno.2006.06.004","article-title":"The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns","volume":"103","author":"Park","year":"2006","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"10.1002\/14651858.CD008765.pub3-BIB0026|cit26","first-page":"1008","article-title":"Secondary cytoreductive surgery for recurrent epithelial ovarian cancer","volume":"99","author":"Tay","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD008765.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2007.04.006","article-title":"Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma","volume":"106","author":"Tebes Stephen","year":"2007","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD008765.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/gyno.1995.1099","article-title":"Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response","volume":"57","author":"Vaccarello","year":"1995","journal-title":"Gynecologic Oncology"},{"issue":"7","key":"10.1002\/14651858.CD008765.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/ejso.2000.0978","article-title":"Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot","volume":"26","author":"Vange","year":"2000","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"issue":"8","key":"10.1002\/14651858.CD008765.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/ejso.2000.1007","article-title":"Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer","volume":"26","author":"Zang","year":"2000","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"issue":"4","key":"10.1002\/14651858.CD008765.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/ijgc-00009577-200307000-00004","article-title":"Surgery and salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma: a retrospective case-control study","volume":"13","author":"Zang","year":"2003","journal-title":"International Journal of Gynecological Cancer"},{"issue":"6","key":"10.1002\/14651858.CD008765.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.20106","article-title":"Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?","volume":"100","author":"Zang","year":"2004","journal-title":"Cancer"},{"issue":"10","key":"10.1002\/14651858.CD008765.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00268-004-7461-x","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer","volume":"28","author":"Zanon","year":"2004","journal-title":"World Journal of Surgery"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0034|cit34","first-page":"326","article-title":"The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery","volume":"25","author":"Boente","year":"1998","journal-title":"Seminars in Oncology"},{"issue":"10","key":"10.1002\/14651858.CD008765.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.1998.16.10.3345","article-title":"Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel","volume":"16","author":"Bookman","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0889-8545(21)00314-4","article-title":"Secondary cytoreductive surgery for ovarian cancer","volume":"21","author":"Burke","year":"1994","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0038|cit38","unstructured":"Common Terminology Criteria for Adverse Events v3.0 www.eortc.be\/services\/doc\/ctc\/ctcaev3.pdf"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0039|cit39","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0090-8258(84)90040-4","article-title":"Stage III epithelial ovarian cancer: the role of maximal surgical reduction","volume":"18","author":"Delgado","year":"1984","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"8","key":"10.1002\/14651858.CD008765.pub3-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007565.pub2","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","author":"Elattar","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","article-title":"EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary","volume":"14 Suppl 5","author":"Sant","year":"2003","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1002\/14651858.CD008765.pub3-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007822.pub2","article-title":"Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer","author":"Galaal","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0045|cit45","unstructured":"Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide globocan.iarc.fr"},{"issue":"10","key":"10.1002\/14651858.CD008765.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z","article-title":"Ovarian carcinoma diagnosis","volume":"89","author":"Goff","year":"2000","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0047|cit47","first-page":"abs 1812","article-title":"Randomized phase II study of carboplatin versus paclitaxel-carboplatin in platinum sensitive recurrent advanced ovarian carcinoma with assessment of quality of life","volume":"22","author":"Gonzalez-Martin","year":"2003","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0048|cit48","first-page":"413","article-title":"Primary cytoreductive surgery for epithelial ovarian cancer","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD008765.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1080\/00016340802483000","article-title":"Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five year relative survival","volume":"87","author":"Hannibal","year":"2008","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0051|cit51","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with sub optimal residual epithelial ovarian carcinoma","volume":"70","author":"Hoskins","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0053|cit53","unstructured":"Parkin DM Whelan SL Ferlay J Teppo L Thomas DB Cancer Incidence in Five Continents, Volume VIII IARC Scientific Publication 2002; No. 155 2002"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0054|cit54","first-page":"71","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"15","key":"10.1002\/14651858.CD008765.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1200\/JCO.2004.05.195","article-title":"Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design","volume":"22","author":"Markman","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008765.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2004.09.018","article-title":"Critical evaluation of secondary cytoreduction in recurrent ovarian cancer","volume":"95","author":"Munkarah","year":"2004","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0057|cit57","first-page":"895","article-title":"Epithelial ovarian cancer","volume-title":"Principles and Practice of Gynecologic Oncology","author":"Ozols","year":"2005"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17(24)","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer. the ICON4\/AGO-OVAR-2-2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.1988.6.6.983","article-title":"The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in Stage III and IV ovarian carcinoma","volume":"6","author":"Piver","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0061|cit61","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0062|cit62","first-page":"1","article-title":"Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament","volume-title":"Atlas of Tumor Pathology","volume":"Fascicle 23 3rd","author":"Scully","year":"1998"},{"issue":"8","key":"10.1002\/14651858.CD008765.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1471-0528.1989.tb03341.x","article-title":"Revised FIGO staging for gynaecological cancer","volume":"96","author":"Shepherd","year":"1989","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD008765.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/cncr.21310","article-title":"Ovarian cancer: can we make the clinical diagnosis earlier?","volume":"104","author":"Smith","year":"2005","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD008765.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0959-8049(11)70152-6","article-title":"Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer","volume":"47 Suppl 3","author":"Vergote","year":"2011","journal-title":"European Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD008765.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21969","article-title":"Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: a retrospective analysis","volume":"107","author":"Wright","year":"2006","journal-title":"Cancer"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008765.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:33:02Z","timestamp":1694417582000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008765.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":66,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008765.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,28]]}}}